From black magic to science: understanding the rationale for the use of intravenous immunoglobulin to treat inflammatory myopathies

Clin Exp Immunol. 2001 May;124(2):169-71. doi: 10.1046/j.1365-2249.2001.01565.x.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Animals
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use*
  • Mice
  • Myositis / etiology
  • Myositis / therapy*
  • Nervous System Autoimmune Disease, Experimental / etiology
  • Nervous System Autoimmune Disease, Experimental / therapy*

Substances

  • Immunoglobulins, Intravenous